The European Business Association (EBA) has prepared more than 500 amendments to the bill on medicines and asks the relevant committee of the parliament to continue dialogue with the industry representatives, according to a press release from the EBA.
“It is necessary to make sure that no artificial barriers are created for the business, and sufficient transition periods are defined for the proposed changes. After all, these issues are interconnected with the availability of drugs for patients. Under any conditions, it is necessary to avoid negative impact on the market and limiting patients’ access to drugs,” the report says.
At the same time, the business community asks the profile committee of the Verkhovna Rada to continue a professional dialogue with representatives of the industry, pointing out that the most effective way of resolving the issue is the general processing of all submitted proposals for the document and mutual approval of the final version of the edition for the second reading. According to the EBA, it is also necessary to involve lawyers, experts of international technical assistance projects, and profile state authorities in the work on the final revisions and the adoption of a new law for the pharmaceutical industry.
“Only by joint efforts will we be able to bring the pharmaceutical industry of Ukraine to the European level and provide Ukrainian patients with effective, high-quality, modern, and safe medicines,” the EBA explains.
